In vivo electrophysiological characterization of TASK-1 deficient mice

Cellular Physiology and Biochemistry

Volumn 30, Issue 3, 2012, Pages 523-537

  Petric, Stella ^a   Clasen, Lukas ^a   Van Weßel, Carina ^a   Geduldig, Nora ^a   Ding, Zhaoping ^b   Schullenberg, Martina ^a   Mersmann, Jan ^c   Zacharowski, Kai ^c   Aller, Maria I ^d,e   Schmidt, Klaus G ^a   Donner, Birgit C ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

Cardiac repolarization; Heart rate turbulence; In vivo electrophysiology; Long QT syndrome (LQTS); Programmed electrical stimulation; Prolonged QT interval; TASK 1 knock out

Indexed keywords

BROMETHOL; ISOFLURANE; PENTOBARBITAL; POTASSIUM CHANNEL; POTASSIUM CHANNEL TASK 1; UNCLASSIFIED DRUG;

ANESTHESIA; ANESTHESIA INDUCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC STIMULATION; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED STUDY; ELECTRIC CONDUCTIVITY; ELECTROSTIMULATION; FEMALE; GENOTYPE; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART RATE; HEART RATE TURBULENCE; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART VENTRICLE EXTRASYSTOLE; HEART VENTRICLE TACHYCARDIA; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SEDATION; TELEMETRY;

MUS;

EID: 84863868206     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000341435     Document Type: Article

References (33)

1. Nattel S, Maguy A, Le Bouter S, Yeh YH: Arrhythmogenic ion-channel remodelling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 2007;87:425-456.
2. Priori SG: The fifteen years of discoveries that shaped molecular electrophysiology Circ Res 2010; 107:451-456.
3. Bayliss DA, Sirois JE, Talley EM: The TASK family: two-pore domain background K*channels. Mol Interv 2003;3:205-219.
4. Lesage F, Lazdunski M: Molecular and functional properties of two-pore-domain potassium channels. Am J Physiol Renal Physiol 2000;279:F793-F801.
5. Putzke C, Wemhöner K, Sachse FB, Rinné S, Schlichthörl G, Li XT, Jae L, Eckhardt I, Wischmeyer E, Wulf H, Preisig-Müller R, Daut J, Decher N: The acid-sensitive potassium channel TASK-1 in rat cardiac muscle. Cardiovasc Res 2007;75:59-68.
6. Barbuti A, Ishii S, Shimizu T, Robinson RB, Feinmark SJ: Block of the background K*channel TASK-1 contributes to arrhythmogenic effects of platelet-activating factor. Am J Physiol Heart Circ Physiol 2002; 282:H2024-H2030.
7. Besana A, Barbuti A, Tateyama MA, Symes A], Robinson RB, Feinmark SJ: Activation of protein kinase Ce inhibits the two-pore domain K*channel, TASK-1, inducing repolarization abnormalities in cardiac ventricular myocytes. Biol Chem 2004;279:33154-33160.
8. Donner BC, Schullenberg M, Geduldig N, Hüning A, Mersmann], Zacharowski K, Kovacevic A, Decking U, Aller MI, Schmidt KG: Functional role of TASK-1 in the heart: studies in TASK-1 deficient mice show prolonged cardiac repolarization and reduced heart rate variability. Basic Res Cardiol 2011;106:75-87.
9. Decher N, Wemhöner K, Rinné S, Netter MF, Zuzarte M, Aller MI, Kaufmann SG, TL Xian, Meuth SG, Daut, Sachse FB, Maier SKG: Knock-out of the potassium channel TASK-1 leads to a prolonged QT interval and a disturbed QRS complex. Cell Physiol Biochem 2011;28:77-86.
10. Limberg SH, Netter MF, Rolfes C, Rinné S, Schlichthörl G, Zuzarte M, Vassiliou T, Moosdorf R, Wulf H, Daut, Sachse FB, Decher N: TASK-1 channels may modulate action potential duration of human atrial cardiomyocytes. Cell Physiol Biochem 2011;28:613-624.
11. Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I, Guzik P, Lombardi F, Müller A, Oto A, Schneider R, Watanabe M, Wichterle D, Zareba W: Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use. Am Coll Cardiol 2008;52:1353-1365.
12. Aller MI, Veale EL, Linden A-M, Sandu C, Schwaninger M, Evans L], Korpi ER, Mathie A, Wisden W, Brickley SG: Modifying the subunit composition of TASK-1 channels alters the modulation of a leak conductance in cerebellar granule neurons. Neurosci 2005;25:11455-11467.
13. Mitchell GF, Jeron A, Koren G: Measurement of heart rate and Q-T interval in the conscious mouse. Am Physiol 1998;274:H747-H751.
14. Sagie A, Larson MG, Goldberg R], Bengston JR, Levy D: An improved method for adjusting the QT interval for heart rate (the Framingham heart study). Am Cardiol 1992;70:797-801.
15. Berul CI: Electrophysiological phenotyping in genetically engineered mice. Physiol Genomics 2003;13:207-216.
16. Schrickel JW, Brixius K, Herr C, Clemen CS, Sasse P, Reetz K, Grohé C, Meyer R, Tiemann K, Schroder R, Bloch W, Nickenig G, Fleischmann BK, Noegel AA, Schwinger RHG, Lewalter T: Enhanced heterogeneity of myocardial conduction and severe cardiac electrical instability in annexin A7-deficient mice. Cardiovasc Res 2007;76:257-268.
17. Petzelbauer P, Zacharowski PA, Miyazaki Y, Friedl P, Wickenhauser G, Castellino F], Gröger M, Wolff K, Zacharowski K: The fibrin-derived peptide Bßl5-42 protects the myocardium against ischemia-reperfusion injury. Nat Med 2005;11:298-304.
18. Luo S, Michler K, Johnston P, Macfarlane PW: A comparison of commonly used QT correction formulae: the effect of heart rate on the QTc of normal ECGs. Electrocardiology 2004;37 Suppl:81-90.
19. Hart CYT, Burnett JC, Redfield MM: Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice. Am Physiol Heart Circ Physiol 2001;281:H1938-1945.
20. Weiergräber M, Henry M, Südkamp M, de Vivie E-R, Hescheler, Schneider T: Ablation of Cav2.3/E-type voltage-gated calcium channel results in cardiac arrhythmia and altered autonomic control within the murine cardiovascular system. Basic Res Cardiol 2005;100:1-13.
21. Zeiler A, Arras M, Jurd R, Rudolph U: Identification of a molecular target mediating the general anesthetic actions of pentobarbital. Mol Pharmacol 2006;71:852-859.
22. Shimizu W McMahon B, Antzelevitch C: Sodium pentobarbital reduces transmural dispersion ofrepolarization and prevents torsades de pointes in models of acquired and congenital long QT syndrome. Cardiovasc Electrophysiol 1999;10:154-164.
23. Patel A], Honoré E, Lesage F, Fink M, Romey G, Lazdunski M: Inhalational anesthetics activate two-pore-domain background K*channels. Nat Neurosci 1999;2:422-426.
24. Ackerman M], Khositseth A, Tester D], Hejlik JB, Shen WK, Porter CB: Epinephrine-induced QT interval prolongation: A gene-specific paradoxical response in congenital long QT syndrome. Mayo Clin Proc 2002;77:413-421.
25. Shimizu W, Antzelevitch C: Differential response to beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. Am Coll Cardiol 2000;35:778-786.
26. Roth DM, Swaney JS, Dalton ND, Gilpin ES, Ross: Impact of anesthesia on cardiac function during echocardiography in mice. Am Physiol Heart Circ Physiol 2002;282:H2134-2140.
27. Chandler NJ, Greener ID, Tellez JO, Inada S, Musa H, Molenaar P, DiFrancesco D, Baruscotti M, Longhi R, Anderson RH, Billeter R, Sharma V, Sigg DC, Boyett MR, Dobrzynski H: Molecular architecture of the human sinus node. Insights into the function of the cardiac pacemaker. Circulation 2009;119:1562-1575.
28. Kim D, Fujita A, Horio Y, Kurachi Y: Cloning and functional expression of a novel cardiac two-pore background K*channel (cTBAK-1). Circ Res 1998;82:513-518.
29. Graham V, Zhang H, Willis S, Creazzo TL: Expression of a two-pore domain K*channel (TASK-1) in developing avian and mouse ventricular conduction systems. Dev Dyn 2006;235:143-151.
30. Barth AS, Merk S, Arnoldi E, Zwermann L, Kloos P, Gebauer M, Steinmeyer K, Bleich M, Kääb S, Hinterseer M, Kartmann H, Kreuzer E, Dugas M, Steinbeck G, Näbauer M: Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature. Circ Res 2005;96:1022-1029.
31. Raj SR, Sheldon RS, Koshman M, Roach DE: Role of hypotension in heart rate turbulence physiology. Heart Rhythm 2005;2:820-827.
32. Roach D, Koshman ML, Duff H, Sheldon R: Induction of heart rate and blood pressure turbulence in the electrophysiologic laboratory. Am Cardiol 2002;90:1098-1102.
33. Casella M, Russo AD, Pace M, Pelargonio G, Ierardi C, Sanna T, Messano L, Bencardino G, Valsecchi S, Mangiola F, Lanza GA, Zecchi P, Créa F, Bellocci F: Heart rate turbulence as a noninvasive risk predictor of ventricular tachyarrhythmias in myotonic dystrophy type 1. Cardiovasc Electrophysiol 2006;17:871-876.